OS6.4 NOA-16: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group evaluating a mutation-specific peptide vaccine targeting IDH1R132H in pati...

Por Platten, M, Schilling, D, Bunse, L, Wick, A, Bunse, T, Riehl, D, Green, E, Sanghvi, K, Karapanagiotou-Schenkel, I, Harting, I, Sahm, F, Steinbach, J, Weyerbrock, A, Hense, J, Misch, M, Krex, D, Setvanovic, S, Tabatabai, G, von Deimling, A, Schmitt, M, Wick, W
Publicado no Neuro Oncol (2018)